Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00LWQ
|
||||
| Former ID |
DNC013709
|
||||
| Drug Name |
3-Bromo-2'-hydroxy-4-methoxychalcone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529976] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H13BrO3
|
||||
| Canonical SMILES |
COC1=C(C=C(C=C1)C=CC(=O)C2=CC=CC=C2O)Br
|
||||
| InChI |
1S/C16H13BrO3/c1-20-16-9-7-11(10-13(16)17)6-8-15(19)12-4-2-3-5-14(12)18/h2-10,18H,1H3/b8-6+
|
||||
| InChIKey |
KXSKRIQLDQIBNJ-SOFGYWHQSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [529976] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.